Alessandra Gennari, MD, PhD, is Associate Professor of Oncology at the University of Eastern Piedmont (UPO) and Head of the Division of Oncology at Maggiore University Hospital, Novara, IT. She is also Head of the Laboratory of Immuno-Oncology at the UPO-CAAD Center for Immune and Allergic Diseases, Novara, IT.

Dr Gennari’s areas of expertise include molecular and therapeutic innovation in breast cancer. Her current research is focused on the identification of individual drug responsiveness in breast tumors and therapy optimization in metastatic breast cancer. Other active research areas include the evaluation of host metabolism in breast cancer, and functional imaging by PET-CT with 18F-FES to evaluate endocrine responsiveness in advanced breast cancer. She is also expanding research interests in immunotherapy and cell senescence for response prediction in breast cancer. She acts as referee for numerous high-profile oncology journals, and has authored more than 100 peer-reviewed publications as well as numerous book chapters, abstracts, and other articles. She is a member of the editorial board of the Cochrane Breast Cancer Group as clinical editor and of the Scientific Board of the International Breast Cancer Study Group (IBCSG). She is the first (lead) author of the ESMO MBC Guidelines.